Structure-Based Design and Optimization Lead to the Identification of a Novel Potent sEH Inhibitor with PPARγ Partial Agonist Activity against Inflammatory and Metabolic-Related Diseases
Ruolin Cao(Shenyang Pharmaceutical University), Guoliang Chen(Shenyang Pharmaceutical University)
Cited by 6
Related Papers
Structure-Directed Discovery of Potent Soluble Epoxide Hydrolase Inhibitors for the Treatment of Inflammatory Diseases
|Journal of Medicinal Chemistry|2023|19
Hes-1-targeting siRNA inhibits the maturation of murine myeloid-derived dendritic cells
|Open Life Sciences|2013|0